Sandra Vukusic

51PUBLICATIONS
180CO-AUTHORS
Gene and molecular therapyMedical microbiology not elsewhere classifiedRegenerative medicine (incl. stem cells)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jun 02, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.

|May 05, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

|Apr 05, 2026
Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: A multinational cohort study.

Chloe Pierret, Geraldine Androdias, Christine Lebrun-Frenay

Pageof 9

Frequent Collaborators

18 joint publications

Xavier Moisset

18 joint publications

Jonathan Ciron

17 joint publications

Christine Lebrun-Frenay

15 joint publications

Eric Thouvenot